Matthew Henn, PhD

EVP, Cheif Scientific Officer
Seres Therapeutics, Cambridge, MA
Cambridge, Massachusetts, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2067 - Preclinical Characterization of Rationally Designed Microbial Consortia to Prevent Bacterial Infections in Patients with Chronic Liver Disease

  Saturday, October 14, 2023
  11:30 AM – 11:43 AM US ET